Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Tallman
    Tallman
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (293)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (15)
  5. Review (11)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (293)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (14)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (350)
  2. Haematologica Meeting Reports (4)

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
    Journal Article

    Marks, D. I.; Moorman, A. V.; Chilton, L.; Paietta, E.; Enshaie, A.; de Wald, G.; Harrison, C. J.; Fielding, A. K.; Foroni, L.; Goldstone, A. H.; more...
    Haematologica (2013)

    Fulltext@MSK | Save
  • Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study
    Journal Article

    Visco, C.; Tzankov, A.; Xu-Monette, Z. Y.; Miranda, R. N.; Tai, Y. C.; Li, Y.; Liu, W. M.; d'Amore, E. S. G.; Montes-Moreno, S.; Dybkær, K.; more...
    Haematologica (2013)

    Fulltext@MSK | Save
  • Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
    Journal Article

    Pollyea, D. A.; Zehnder, J.; Coutre, S.; Gotlib, J. R.; Gallegos, L.; Abdel-Wahab, O.; Greenberg, P.; Zhang, B.; Liedtke, M.; Berube, C.; more...
    Haematologica (2013)

    Fulltext@MSK | Save
  • Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: A registry study from the center for international blood and marrow transplantation research
    Journal Article

    Keating, A.; DaSilva, G.; Pérez, W. S.; Gupta, V.; Cutler, C. S.; Ballen, K. K.; Cairo, M. S.; Camitta, B. M.; Champlin, R. E.; Gajewski, J. L.; more...
    Haematologica (2013)

    Fulltext@MSK | Save
  • Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia
    Journal Article

    Sekeres, M. A.; Lancet, J. E.; Wood, B. L.; Grove, L. E.; Sandalic, L.; Sievers, E. L.; Jurcic, J. G.
    Haematologica (2013)

    Fulltext@MSK | Save
  • Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials
    Journal Article

    Tang, M.; Foo, J.; Gonen, M.; Guilhot, J.; Mahon, F.; Michor, F.
    Haematologica (2012)

    Fulltext@MSK | Save
  • A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
    Journal Article

    Wilson, W. H.; Jung, S. H.; Porcu, P.; Hurd, D.; Johnson, J.; Eric Martin, S.; Czuczman, M.; Lai, R.; Said, J.; Chadburn, A.; more...
    Haematologica (2012)

    Fulltext@MSK | Save
  • DNMT3A and stem cell function: New insights into old pathways
    Journal Article

    Guryanova, O.; Levine, R.
    Haematologica (2012)

    Fulltext@MSK | Save
  • Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: A series of nine patients and a review of the literature
    Journal Article

    Araten, D. J.; Notaro, R.; Thaler, H. T.; Kernan, N.; Boulad, F.; Castro-Malaspina, H.; Small, T.; Scaradavou, A.; Magnan, H.; Prockop, S.; more...
    Haematologica (2012)

    Fulltext@MSK | Save
  • ETV6-ABL1-positive "chronic myeloid leukemia": Clinical and molecular response to tyrosine kinase inhibition
    Journal Article

    Perna, F.; Abdel-Wahab, O.; Levine, R. L.; Jhanwar, S. C.; Imada, K.; Nimer, S. D.
    Haematologica (2011)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: